Mangrove Partners’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-368,000
| Closed | -$2.03M | – | 525 |
|
|
2022
Q1 | $2.03M | Sell |
368,000
-320,000
| -47% | -$1.76M | 0.11% | 256 |
|
|
2021
Q4 | $5.86M | Buy |
688,000
+188,000
| +38% | +$1.6M | 0.35% | 56 |
|
|
2021
Q3 | $4.35M | Buy |
500,000
+14,632
| +3% | +$127K | 0.39% | 70 |
|
|
2021
Q2 | $5.13M | Hold |
485,368
| – | – | 0.53% | 32 |
|
|
2021
Q1 | $7.79M | Buy |
+485,368
| New | +$7.79M | 0.79% | 19 |
|
|
2020
Q4 | – | Sell |
-230,307
| Closed | -$8.11M | – | 107 |
|
|
2020
Q3 | $8.11M | Buy |
230,307
+100,000
| +77% | +$3.52M | 1.02% | 30 |
|
|
2020
Q2 | $3.17M | Sell |
130,307
-441,635
| -77% | -$10.8M | 0.77% | 29 |
|
|
2020
Q1 | $8.9M | Buy |
571,942
+471,942
| +472% | +$7.35M | 1.23% | 22 |
|
|
2019
Q4 | $1.59M | Hold |
100,000
| – | – | 0.23% | 37 |
|
|
2019
Q3 | $1M | Buy |
+100,000
| New | +$1M | 0.12% | 72 |
|